Action required: Please refresh your browser
We have recently implemented some changes that require a hard refresh of your browser: Please hold down the CTRL-key and press the F5 key.
After a successful hard refresh, this message should not appear anymore.
More details about this topic are available here »
| Dr. Debashish Bose of The Institute for Cancer Care at Mercy Featured on "Medoscopy" | ||
| By: PR Newswire Association LLC. - 22 Nov 2022 | Back to overview list |
|
|
Mercy surgical oncologist Dr. Debashish Bose, noted for his work in treatment of pancreatic cancer, is guest for the November 2022 edition of Mercy's monthly talk show, "Medoscopy". November is Pancreatic Cancer Awareness Month. BALTIMORE, Nov. 22, 2022 /PRNewswire-PRWeb/ -- Debashish Bose, M.D., PhD, FACS, Medical Director of Surgical Oncology at Mercy and The Center for Hepatobiliary Disease at Mercy, is the guest for the hospital's ongoing talk show series, "Medoscopy," airing on Facebook Watch, Tues.-Wed., Nov. 29th and 30th at 5:30 p.m. EST (http://www.facebook.com/MercyMedicalCenter). A 30-minute pre-taped program that explores the background and lives of Mercy clinicians, patients and others, Medoscopy was launched in spring 2021 and airs in two 15-minute segments. To view past episodes, visit the Medoscopy playlist on the Mercy Medical Center YOUTUBE channel. In this latest installment, timed for November – Pancreatic Cancer Awareness Month – Dr. Bose discusses his work with cutting-edge cancer treatment options, including minimally invasive and robotic surgery for late-stage and complex oncologic disease such as liver cancer and pancreatic cancer. On more personal notes, Dr. Bose discusses his time "working (at Mercy) various jobs in the summers as a young person, and as a volunteer when I was in high school." Though he briefly contemplated politics as a potential career, the influence of parents – both doctors – and family friends who were also physicians, helped set his path toward medicine. Dr. Bose is one of the region's leading surgeons in the use of the NanoKnife System to treat pancreatic cancer, liver cancer, small tumors and recurrent disease. The NanoKnife System is next-generation technology involving low-current, high-voltage electrical energy, used to treat diseased tissue without damaging surrounding healthy cells. Dr. Bose works in close collaboration with the liver and pancreatic experts at Mercy's Institute for Digestive Health and Liver Disease. Medoscopy is filmed on the campus of Mercy Medical Center in downtown Baltimore with video, sound, and lighting by Zinnia Film. Founded in 1874 by the Sisters of Mercy, Mercy Medical Center is located in downtown Baltimore City, about six blocks from Baltimore's famed Inner Harbor. A university-affiliated teaching facility, Mercy is a Catholic hospital with a national reputation for women's health care, orthopedics, and other specialties. Mercy is home to the renowned Weinberg Center for Women's Health & Medicine, and the $400+ million Mary Catherine Bunting Center. For more information, visit http://www.mdmercy.com, and MDMercyMedia on Facebook and Twitter, or call 1-800-M.D.-Mercy. Media Contact Dan Collins, Mercy Medical Center, 4103329714, dcollins@mdmercy.com
SOURCE Mercy Medical Center 
|
||
|
|
||
 | Back to overview list | |